Joy Ventures

Joy Ventures, now rebranded as Corundum Neuroscience, is a venture capital firm originally founded in 2017 and based in Herzliya, Israel. The firm has transitioned its focus to become a neuroscience-focused venture builder and fund. Under its new identity, Corundum Neuroscience aims to drive innovation in neuroscience by investing in and supporting early-stage companies that develop groundbreaking consumer products and technologies rooted in scientific research. The firm specializes in nurturing startups at various stages, from seeding ideas to advancing them through the critical phases of development. Corundum Neuroscience emphasizes creating products that enhance emotional and mental well-being, reflecting its deep commitment to improving human health through innovative technologies. The firm’s strategy includes providing not just financial backing but also extensive resources such as mentorship, strategic guidance, and access to a network of experts in neuroscience and related fields. With its rebranding, Corundum Neuroscience is positioned to become a leader in the neuroscience sector, fostering the development of cutting-edge solutions that address some of the most pressing challenges in mental health and cognitive sciences.